Steven Longobardi
Interventional Cardiology · Fort Myers, FLNPI 1619907177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,100 and has fallen 97.1% since, to $32 in 2025. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.
Across 149 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$628
- Johnson & Johnson$539
- Boehringer Ingelheim$424
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$281
- Novartis$226
- Novo Nordisk$193
- plus $465 from 7 others
What the payments were for
- Food & beverage$2,69298%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 45 | $628 |
| Johnson & Johnson | 56 | $539 |
| Boehringer Ingelheim | 10 | $424 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $281 |
| Novartis | 20 | $226 |
| Novo Nordisk | 5 | $193 |
| Braemar Manufacturing, LLC | 1 | $161 |
| Astellas Pharma US Inc | 3 | $136 |
| E.r. Squibb & Sons, L.L.C. | 2 | $92 |
| Terumo Medical Corporation | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $18 |
| Amgen | 1 | $17 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,757 in reported general payments places this provider in the 20th percentile of 623 interventional cardiology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 15 | $292 |
| Ranolazine ErRanolazine | 12 | $218 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Fort Myers
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
- Miguel DiazHialeah$383K
- Douglas EbersoleLakeland$373K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.